ACMA President Monty Felix Responds to NTP Styrene Listing

14 June 2011

The American Composites Manufacturers Association (ACMA) has issued a statement in response to the US Department of Health and Human Services’ listing of styrene in its 12th Report on Carcinogens (RoC).

The RoC listed styrene as a substance that is “reasonably anticipated to be a human carcinogen”. This statement may be attributed in whole or in part to ACMA President, Monty Felix.

“We are very disappointed that the National Toxicology Program failed to address the styrene industries and Congress’ legitimate concerns in its 12th Report on Carcinogens. It is the position of ACMA, as well as leaders in the scientific community, that styrene does not pose a cancer risk.

“European Union scientists recently completed an exhaustive review of styrene’s health effects and concluded that exposure to styrene is not likely to cause cancer in humans – a conclusion validated by a myriad of peer-reviewed studies in the United States. In addition, other federal agencies, including OSHA and EPA are aware of the scientific data on the possible linkage between exposure to styrene and development of cancer and have not concluded that there is sufficient risk to require additional regulatory protections.

“It is important to note that the RoC does not present quantitative assessments of carcinogenic risk. Listing in the RoC does not establish that styrene presents a risk to people in their daily lives.

“More than 750,000 Americans are employed in jobs that depend on styrene. Historically, people have worked safely for 50 years with styrene in the United States and Europe. Several long-term studies examined 60,000 health records of workers exposed to styrene. These findings showed no significant health problems linked to styrene exposure.”

Further to Felix’s response, the Styrene Information and Research Center (SIRC) have stated, on behalf of the US styrene industry, how they will also contest the listing.

Share this story